Diagnosis and treatment of atherosclerotic renal artery stenosis (ARAS)

Minerva Urologica e Nefrologica

Volumn 54, Issue 1, 2002, Pages 29-36

  Geddes, C C ^a,b   Jardine, A G ^b  

^a Renal Unit   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Angioplasty, balloon; Atherosclerosis; Magnetic resonance angiography; Renal artery obstruction, therapy; Stents

Indexed keywords

ARTERIOSCLEROSIS; HUMAN; KIDNEY ARTERY STENOSIS; PATHOPHYSIOLOGY; REVIEW;

ARTERIOSCLEROSIS; HUMANS; RENAL ARTERY OBSTRUCTION;

EID: 0036511089     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Pickering TG. Renovascular hypertension: etiology and pathophysiology. Semin Nucl Med 1989;19:79-88.
2. Lewin A, Blaufox MD, Castle H, Entwisle G, Langford H. Apparent prevalence of curable hypertension in the hypertension detection and follow-up program. Arch Intern Med 1985;145:424-7.
3. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001;37:1184-90.
4. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;24:622-9.
5. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993;118:712-9.
6. Leertouwer TC, Pattynama PM, Berg-Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int 2001;59:1480-3.
7. Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E et al. Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 2000;36: 1089-109.
8. Connolly JO, Higgins RM, Walters HL, Mackie AD, Drury PL. Hendry BM et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM 1994;87:413-21.
9. Baboolal K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998;31:971-7.
10. Pohl MA, Novick AC. Natural history of atherosclerotic and fibrous renal artery disease: clinical implications. Am J Kidney Dis 1985;5:A120-30.
11. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-72.
12. Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998;53:735-42.
13. Ying CY, Tifft CP, Gavras H, Chobanian AV. Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 1984;311:1070-5.
14. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992;2:1608-16.
15. Choudhri AH, Cleland JG, Rowlands PC, Tran TL, McCarty M, al Kutoubi MA. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ 1990;301:1197-8.
16. Metcalfe W, Reid AW, Geddes CC. Prevalence of angiographic atherosclerotic renal artery disease and its relationship to the anatomical extent of peripheral vascular atherosclerosis. Nephrol Dial Transplant 1999;14: 105-8.
17. Pickering TG, Herman L, Devereux RB, Sotelo JE, James GD, Sos TA et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 1988;2:551-2.
18. Leung DA, Hoffmann U, Pfammatter T, Hany TF, Rainoni L, Hilfiker P et al. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease. Hypertension 1999;33:726-31.
19. Ghantous VE, Eisen TD, Sherman AH, Finkelstein FO. Evaluating patients with renal failure for renal artery stenosis with gadolinium-enhanced magnetic resonance angiography. Am J Kidney Dis 1999;33:36-42.
20. Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1997;96:2751-3.
21. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-81.
22. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.
23. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998;97:946-52.
24. Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension 1997;29:641-50.
25. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-16.
26. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998;339:1972-8.
27. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329-35.
28. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic-renal artery stenosis: a randomized trial. Essai Multi-centrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823-9.
29. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353:282-6.
30. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in 10 studies. QJM 1999;92:159-67.
31. Dejani H, Eisen TD, Finkelstein FO. Revascularization of renal artery stenosis in patients with renal insufficiency. Am J Kidney Dis 2000;36:752-8.
32. Novick AC, Ziegelbaum M, Vidt DG, Gifford RW Jr, Pohl MA, Goormastic M. Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA 1987;257:498-501.
33. Libertino JA, Bosco PJ, Ying CY, Breslin DJ, Woods BO, Tsapatsaris NP et al. Renal revascularization to preserve and restore renal function. J Urol 1992:147: 1485-7.
34. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthen L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993;18:841-50.
35. Andersen GS, Gadsboll N, McNair A, Leth A, Giese J, Munck O et al. Treatment of renovascular hypertension by unilateral nephrectomy. A follow-up study in patients above 60 years of age. Scand J Urol Nephrol 1986;20:51-6.
36. Mackay A, Brown JJ, Lever AF, Robertson JI. Reconstructive surgery versus nephrectomy in renal artery stenosis: comparison of effects on total and divided renal function and on blood pressure. Br Med J 1980;281:1313-5.
37. Farmer CK, Cook GJ, Blake GM, Reidy J, Scoble JE. Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis. Nephrol Dial Transplant 1999;14:2880-4.
38. Shanley PF. The pathology of chronic renal ischemia. Semin Nephrol 1996;16:21-32.
39. Wright JR, Duggal A, Thomas R, Reeve R, Roberts IS, Kalra PA. Clinicopathological correlation in biopsyproven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant 2001;16: 765-70.
40. Jensen G, Aurell M. Individual kidney function before and after renal angioplasty. Lancet 1998;352:1150.
41. Farmer CK, Reidy J, Kalra PA, Cook GJ, Scoble J. Individual kidney function before and after renal angioplasty. Lancet 1998;352:288-9.
42. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987; 316:1429-35.
43. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-91.
44. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
45. Jamali AH, Tang WH, Khot UN, Fowler MB. The role of angiotensin receptor blockers in the management of chronic heart failure. Arch Intern Med 2001;161:667-72.
46. Sigwart U, Prasad S, Radke P, Nadra I. Stent coatings. J Invasive Cardiol 2001;13:141-2.